ArticleActa diabetologica2025

Correction: Different formulations of semaglutide and oxidative stress in subjects with type 2 diabetes and MASLD: an open-label, real-life study.

Giovanni Petralli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.